These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 25791989

  • 1. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU, Martens JW, Sieuwerts AM, van Deurzen CH, Koelewijn SJ, de Blois E, Maina T, Nock BA, Brunel L, Fehrentz JA, Martinez J, de Jong M, Melis M.
    J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
    [Abstract] [Full Text] [Related]

  • 2. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
    Maddalena ME, Fox J, Chen J, Feng W, Cagnolini A, Linder KE, Tweedle MF, Nunn AD, Lantry LE.
    J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
    [Abstract] [Full Text] [Related]

  • 3. Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
    Maina T, Nock BA, Zhang H, Nikolopoulou A, Waser B, Reubi JC, Maecke HR.
    J Nucl Med; 2005 May; 46(5):823-30. PubMed ID: 15872357
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S, Wuest M, Krieger SS, Rogers BE, Friebe M, Bergmann R, Wuest F.
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [Abstract] [Full Text] [Related]

  • 5. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ, Maina T, Sallegger W, Krenning EP, de Jong M, Nock BA.
    J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
    [Abstract] [Full Text] [Related]

  • 6. 177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.
    Lantry LE, Cappelletti E, Maddalena ME, Fox JS, Feng W, Chen J, Thomas R, Eaton SM, Bogdan NJ, Arunachalam T, Reubi JC, Raju N, Metcalfe EC, Lattuada L, Linder KE, Swenson RE, Tweedle MF, Nunn AD.
    J Nucl Med; 2006 Jul; 47(7):1144-52. PubMed ID: 16818949
    [Abstract] [Full Text] [Related]

  • 7. Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of (177)Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor-positive prostate tumor targeting.
    Lim JC, Cho EH, Kim JJ, Choi SM, Lee SY, Nam SS, Park UJ, Park SH.
    Nucl Med Biol; 2015 Mar; 42(3):234-41. PubMed ID: 25498002
    [Abstract] [Full Text] [Related]

  • 8. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA, de Jong M, Erion JL, Bugaj JE, Srinivasan A, Bernard BF, Kwekkeboom DJ, Visser TJ, Krenning EP.
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [Abstract] [Full Text] [Related]

  • 9. In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues.
    Thomas R, Chen J, Roudier MM, Vessella RL, Lantry LE, Nunn AD.
    Clin Exp Metastasis; 2009 Dec; 26(2):105-19. PubMed ID: 18975117
    [Abstract] [Full Text] [Related]

  • 10. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
    García Garayoa E, Schweinsberg C, Maes V, Rüegg D, Blanc A, Bläuenstein P, Tourwé DA, Beck-Sickinger AG, Schubiger PA.
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
    [Abstract] [Full Text] [Related]

  • 11. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S, García Garayoa E, Maes V, Brans L, Tourwé DA, Müller C, Schibli R.
    Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
    [Abstract] [Full Text] [Related]

  • 12. Bombesin receptor antagonists may be preferable to agonists for tumor targeting.
    Cescato R, Maina T, Nock B, Nikolopoulou A, Charalambidis D, Piccand V, Reubi JC.
    J Nucl Med; 2008 Feb; 49(2):318-26. PubMed ID: 18199616
    [Abstract] [Full Text] [Related]

  • 13. SSTR-Mediated Imaging in Breast Cancer: Is There a Role for Radiolabeled Somatostatin Receptor Antagonists?
    Dalm SU, Haeck J, Doeswijk GN, de Blois E, de Jong M, van Deurzen CHM.
    J Nucl Med; 2017 Oct; 58(10):1609-1614. PubMed ID: 28450563
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides.
    Mansi R, Wang X, Forrer F, Kneifel S, Tamma ML, Waser B, Cescato R, Reubi JC, Maecke HR.
    Clin Cancer Res; 2009 Aug 15; 15(16):5240-9. PubMed ID: 19671861
    [Abstract] [Full Text] [Related]

  • 15. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.
    Int J Pharm; 2009 Jun 22; 375(1-2):75-83. PubMed ID: 19393305
    [Abstract] [Full Text] [Related]

  • 16. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
    Okarvi SM, Jammaz IA.
    Nucl Med Biol; 2012 Aug 22; 39(6):795-804. PubMed ID: 22381782
    [Abstract] [Full Text] [Related]

  • 17. Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.
    Waser B, Eltschinger V, Linder K, Nunn A, Reubi JC.
    Eur J Nucl Med Mol Imaging; 2007 Jan 22; 34(1):95-100. PubMed ID: 16909223
    [Abstract] [Full Text] [Related]

  • 18. Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors.
    Shirmardi SP, Gandomkar M, Maragheh MG, Shamsaei M.
    Cancer Biother Radiopharm; 2011 Jun 22; 26(3):309-16. PubMed ID: 21711115
    [Abstract] [Full Text] [Related]

  • 19. Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts.
    Schroeder RP, de Visser M, van Weerden WM, de Ridder CM, Reneman S, Melis M, Breeman WA, Krenning EP, de Jong M.
    Int J Cancer; 2010 Jun 15; 126(12):2826-34. PubMed ID: 19876914
    [Abstract] [Full Text] [Related]

  • 20. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor.
    Parry JJ, Andrews R, Rogers BE.
    Breast Cancer Res Treat; 2007 Jan 15; 101(2):175-83. PubMed ID: 16838112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.